Shares of Inventiva S.A. Sponsored ADR (IVA) have gained 3.6% over the past four weeks to close the last trading session at $6.55, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $15.48 indicates a potential upside of 136.3%.The mean estimate comprises 12 short-term price targets with a standard deviation of $5.56. While the lowest estimate of $8.80 indicates a 34.4% increase fr ...

Shares of Auna S.A. (AUNA) have gained 9.7% over the past four weeks to close the last trading session at $5.32, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $6.88 indicates a potential upside of 29.3%.The average comprises five short-term price targets ranging from a low of $6.00 to a high of $9.00, with a standard deviation of $1.24. While the lowest estimate indicates an i ...

Carriage Services (CSV) closed the last trading session at $45.19, gaining 6.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $60.25 indicates a 33.3% upside potential.The mean estimate comprises four short-term price targets with a standard deviation of $3.69. While the lowest estimate of $56.00 indicates a 23.9% increase from the current price level, the most optimistic analyst ...

Core Viewpoint - Rush Street Interactive, Inc. (RSI) shows potential for significant upside, with a mean price target of $24.33 indicating a 30.4% increase from the current price of $18.66 [1] Price Targets and Analyst Consensus - The average price target consists of nine estimates ranging from a low of $20.00 to a high of $30.00, with a standard deviation of $2.69, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 7.2% increase, while the highest suggests a 60.8% upside, highlighting the range of analyst expectations [2] - A low standard deviation indicates strong agreement among analysts regarding the stock's price movement direction, which can be a starting point for further research [9] Earnings Estimates and Analyst Optimism - Analysts have shown increasing optimism about RSI's earnings prospects, as evidenced by a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the last 30 days, two EPS estimates have been revised upward, leading to a 13.9% increase in the Zacks Consensus Estimate [12] Zacks Rank and Investment Potential - RSI holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the implied direction of price movement appears to be a useful guide for investors [14]

分组1 - Copa Holdings (CPA) closed at $139.34, with a 4.4% gain over the past four weeks, and a mean price target of $180.2 indicating a 29.3% upside potential [1] - The mean estimate consists of 10 short-term price targets with a standard deviation of $18.72, where the lowest estimate is $150.00 (7.7% increase) and the highest is $212.00 (52.2% increase) [2] - Analysts show strong agreement in revising earnings estimates higher, which correlates with potential stock price increases [4][11] 分组2 - The Zacks Consensus Estimate for the current year has increased by 4.4% over the past month, with four estimates going higher and no negative revisions [12] - CPA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates [13] - While consensus price targets may not be reliable for exact gains, they can indicate the direction of price movement [14]

Core Viewpoint - EuroDry (EDRY) shares have increased by 27.6% over the past four weeks, closing at $16.9, with a mean price target of $22.83 indicating a potential upside of 35.1% [1] Price Targets and Analyst Estimates - The mean estimate consists of three short-term price targets with a standard deviation of $2.57, where the lowest estimate of $20.00 suggests an 18.3% increase, and the highest estimate of $25.00 indicates a 47.9% surge [2] - Analysts' price targets can often mislead investors, as empirical research shows that they rarely indicate the actual price direction of a stock [7] - A low standard deviation among price targets suggests a high degree of agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Sentiment - Analysts have shown increasing optimism about EDRY's earnings prospects, with a strong consensus in revising EPS estimates higher, which correlates with potential stock price increases [11] - Over the past 30 days, one estimate has increased, leading to a Zacks Consensus Estimate rise of 93.2% [12] - EDRY holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [13]

Group 1 - Zebra Technologies (ZBRA) shares have increased by 3.9% over the past four weeks, closing at $252.52, with a mean price target of $348.5 indicating a potential upside of 38% [1] - The average of 14 short-term price targets ranges from a low of $294.00 to a high of $421.00, with a standard deviation of $33.34, suggesting a potential increase of 16.4% to 66.7% from the current price [2] - Analysts show strong agreement on ZBRA's ability to report better earnings than previously predicted, which supports the view of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for the current year has risen by 4.4% over the past month, with three estimates increasing and no negative revisions [12] - ZBRA holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential for upside [13] - While consensus price targets may not be entirely reliable, the direction they imply appears to be a good guide for potential price movement [14]

Group 1 - Replimune Group, Inc. (REPL) shares have increased by 0.7% over the past four weeks, closing at $7.76, with a mean price target of $12.86 indicating a potential upside of 65.7% [1] - The average of seven short-term price targets ranges from a low of $10.00 to a high of $19.00, with a standard deviation of $3.02, suggesting a potential increase of 28.9% to 144.9% from the current price [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate for the current year increasing by 3.5% over the past month, indicating positive sentiment about the company's earnings prospects [11][12] Group 2 - REPL holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [13] - While price targets are often viewed as unreliable indicators, the direction implied by these targets suggests a positive outlook for REPL [14]

Core Viewpoint - EZcorp (EZPW) has shown a significant price increase of 15.9% over the past four weeks, with a mean price target of $31.5 indicating a potential upside of 27.3% from the current price of $24.74 [1] Price Targets and Analyst Estimates - The mean estimate consists of six short-term price targets with a standard deviation of $4.76, where the lowest estimate is $25.00 (1.1% increase) and the highest is $36.00 (45.5% increase) [2] - A low standard deviation suggests a strong agreement among analysts regarding the stock's price movement, which can serve as a starting point for further research [9] Earnings Estimates and Analyst Agreement - Analysts have shown strong agreement in revising EPS estimates higher, which correlates with potential stock price increases [11] - The Zacks Consensus Estimate for the current year has risen by 24.1% over the past month, indicating positive sentiment as there have been no negative revisions [12] - EZPW holds a Zacks Rank 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] Caution on Price Targets - While price targets are often sought after, they can mislead investors, and reliance solely on them may lead to poor investment decisions [3][7][10] - Analysts may set overly optimistic price targets due to business incentives, which can inflate expectations [8]

Core Viewpoint - Terns Pharmaceuticals, Inc. (TERN) shows potential for significant upside, with a mean price target of $58.13 indicating a 50.9% increase from its current price of $38.52 [1] Price Targets and Analyst Estimates - The mean estimate consists of eight short-term price targets, with a standard deviation of $5.19, indicating variability among analysts [2] - The lowest estimate is $54.00, suggesting a 40.2% increase, while the highest estimate is $70.00, indicating an 81.7% potential surge [2] - Analysts' price targets should be approached with caution, as they may not always accurately reflect future stock movements [3][10] Earnings Estimates and Analyst Agreement - Analysts are optimistic about TERN's earnings prospects, with a consensus indicating better-than-previously estimated earnings [4][11] - Over the past 30 days, one earnings estimate has increased, leading to a 5.5% rise in the Zacks Consensus Estimate for the current year [12] - TERN holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors [13] Implications of Price Target Clustering - A low standard deviation in price targets suggests a high degree of agreement among analysts regarding the stock's price direction [9] - While price targets can provide a starting point for further research, they should not be the sole basis for investment decisions [10][14]